CSG is trading 4.17% up at €19.22 after strong first-half 2026 results.
- Revenue rose 17.2% to €3.25 billion, while operating EBIT increased 12.7% to €784 million.
- Management reaffirmed full-year guidance and reported a €17 billion backlog.
- On August 11, CSG agreed with Poland’s Dezamet on a more-than-€100 million deal for 155 mm artillery-ammunition components; the broader market was broadly quiet, making company-specific news the clearest catalyst.